Highlights of the XIX International Congress of Clinical Chemistry

James D. Faix, MD

Disclosures

December 01, 2005

In This Article

Introduction: Cardiac Markers: Something Old, Something New

This update is based on a lecture given by Elliott Antman, MD,[1] cardiologist and clinical researcher at Harvard Medical School and Brigham and Women's Hospital in Boston, Massachusetts, and a symposium entitled "Novel Cardiac Biomarkers and Approaches: Indications, Consternations and Translations."[2] Both were given on July 25, 2005 in Orlando, Florida, as part of the 19th International Congress of Clinical Chemistry, hosted by the American Association for Clinical Chemistry, the Canadian Society of Clinical Chemists, and the Mexican Association for Clinical Biochemistry. The speakers at the symposium included Alan H.B. Wu, PhD (director of Clinical Chemistry at San Francisco General Hospital); Christopher deFilippi, MD (a clinician and researcher at University of Maryland School of Medicine); K-T Jerry Yeo, PhD (director of Clinical Chemistry at Dartmouth-Hitchcock Medical Center); David Morrow, MD, MPH (a colleague of Dr. Antman at Harvard Medical School); and Robert H. Christenson, PhD (a colleague of Dr. deFilippi at University of Maryland School of Medicine).

Editor's note: The symposium entitled "Novel Cardiac Biomarkers and Approaches: Indications, Consternations and Translations" was sponsored by Dade Behring, Inc.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....